Follow the BioVersys AG share price and the full directors' dealings record of the company, a publicly traded company based in Switzerland. Shares trade on CH CH, under the oversight of SIX SER. Operating in the Health Care sector, BioVersys AG has recorded 6 insider filings. Market capitalisation: €155.6m. The latest transaction was filed on 14 May 2026 (Purchase). Among the most active insiders: Anonymous (Non-executive member of the board of directors). All data is openly available.
6
Insider Decl.
0
Thresholds
€5,617
4 ops.
Buy Volume
·
0 ops.
Sell Volume
33Σ signal
Buys €5,617· Sells
Informational score on this market. Our backtest validates the signal only on 8 EU venues; elsewhere (notably US markets) insider buys historically invert or do not hold. Not a recommendation.
Σ
Sigma AI Analysis
Fundamental view, insider signal, bull and bear case, synthesis.
AI-generated analysis. Opinion, not investment advice. Not backtested. Built from public filings and financials. No price target, no buy or sell recommendation.
Last declaration on 14 May 2026
Declarations6 total
●
Anonymous (a non-executive member of the board of directors)
a non-executive member of the board of directors·Executives·(filed)